Search research articles
Contact Us
Filters
Showing results (571-580 of 711) with videos related to
Page
of 72
Sort By:
JAMA Cardiology
|
October 4, 2017
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy
Ann Marie Navar, Benjamin Taylor, Hillary Mulder, et al.
Circulation
|
December 28, 2018
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Michael J Pencina, Ann Marie Navar, Daniel Wojdyla, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
County-level phenomapping to identify disparities in cardiovascular outcomes: An unsupervised clustering analysis: Short title: Unsupervised clustering of counties and risk of cardiovascular mortality
Matthew W Segar, Shreya Rao, Ann Marie Navar, et al.
JAMA Cardiology
|
July 20, 2016
Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States
Jerry C Lee, Tomasz Zdrojewski, Michael J Pencina, et al.
American Heart Journal
|
September 20, 2015
Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events
Min Jung Ko, Yun Jung Kim, Chan Mi Park, et al.
Pharmacoepidemiology and Drug Safety
|
December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies
Sara N Levintow, Kate K Orroth, Alexander Breskin, et al.
Federation Proceedings
|
December 1, 1986
Direct assessment of renal microcirculatory dynamics
L G Navar, J P Gilmore, W L Joyner, et al.
Clinical Cardiology
|
June 5, 2021
Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries
Ann Marie Navar, Simon T Matskeplishvili, Miguel Urina-Triana, et al.
American Journal of Physiology. Renal Physiology
|
November 27, 2015
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
Alexis A Gonzalez, Flavia Cifuentes-Araneda, Cristobal Ibaceta-Gonzalez, et al.
American Heart Journal
|
December 12, 2017
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project
Paul L Hess, Kevin Kennedy, Michael Cowherd, et al.
Page
of 72
Search research articles
Search
Showing results (571-580 of 711) with videos related to
Sort By:
Page
of 72
JAMA Cardiology
|
October 4, 2017
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor Therapy
Ann Marie Navar, Benjamin Taylor, Hillary Mulder, et al.
Circulation
|
December 28, 2018
Quantifying Importance of Major Risk Factors for Coronary Heart Disease
Michael J Pencina, Ann Marie Navar, Daniel Wojdyla, et al.
American Journal of Preventive Cardiology
|
July 30, 2021
County-level phenomapping to identify disparities in cardiovascular outcomes: An unsupervised clustering analysis: Short title: Unsupervised clustering of counties and risk of cardiovascular mortality
Matthew W Segar, Shreya Rao, Ann Marie Navar, et al.
JAMA Cardiology
|
July 20, 2016
Population Effect of Differences in Cholesterol Guidelines in Eastern Europe and the United States
Jerry C Lee, Tomasz Zdrojewski, Michael J Pencina, et al.
American Heart Journal
|
September 20, 2015
Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events
Min Jung Ko, Yun Jung Kim, Chan Mi Park, et al.
Pharmacoepidemiology and Drug Safety
|
December 11, 2021
Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies
Sara N Levintow, Kate K Orroth, Alexander Breskin, et al.
Federation Proceedings
|
December 1, 1986
Direct assessment of renal microcirculatory dynamics
L G Navar, J P Gilmore, W L Joyner, et al.
Clinical Cardiology
|
June 5, 2021
Prospective evaluation of lipid management following acute coronary syndrome in non-Western countries
Ann Marie Navar, Simon T Matskeplishvili, Miguel Urina-Triana, et al.
American Journal of Physiology. Renal Physiology
|
November 27, 2015
Vasopressin/V2 receptor stimulates renin synthesis in the collecting duct
Alexis A Gonzalez, Flavia Cifuentes-Araneda, Cristobal Ibaceta-Gonzalez, et al.
American Heart Journal
|
December 12, 2017
Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project
Paul L Hess, Kevin Kennedy, Michael Cowherd, et al.
Page
of 72